Lymphocytes Regulate Expression of the SARS-CoV-2 Cell Entry Factor ACE2 in the Pancreas of T2DM Patients.

Increased blood glucose levels are associated with increased ACE2 expression and an increased number of lymphocytes. At the same time, lymphocytes can promote ACE2 expression.